Eradication of methicillin-resistant Staphylococcus aureus with an antiseptic soap and nasal mupirocin among colonized patients – an open uncontrolled clinical trial
Open Access
- 1 January 2004
- journal article
- Published by Springer Nature in Annals of Clinical Microbiology and Antimicrobials
- Vol. 3 (1) , 9
- https://doi.org/10.1186/1476-0711-3-9
Abstract
Aim of the study was to determine the clinical efficacy of a new antiseptic liquid soap (Stellisept® scrub), based on the combination of undecylenamidopropyltrimonium methosulphate (4%) and phenoxyethanol (2%), for eradication of MRSA among colonized patients who do not receive antibiotic therapy. Over two years 50 MRSA patients in 6 hospitals were observed. Treatment was defined as the daily application of Stellisept scrub for the antiseptic body and hair wash (at least 60 s) in combination with nasal mupirocin. A treatment cycle was a minimum of 5 days treatment. Screening was carried out at least 48 h after the treatment cycle was finished, with 24 h between each of the requested three or more samplings, which included the nasopharynx, groin, axilla, perineum and other MRSA-positive skin areas. Fifteen cases were retrospectively excluded (lack of outcome documentation, concomitant antibiotic therapy, open wounds). All 35 patients had colonization with MRSA before antiseptic treatment on the skin, in the groin (80%), the axilla (25.7%), the perineum (20%) or other skin areas (14.3%). Colonization at more than one skin sites was found in 34.3%. Nasal colonization was found in 21 of 28 patients (75%), 7 patients were without nasal screening prior to the antiseptic treatment. After one treatment cycle MRSA was eradicated in 25 patients (71.4%), after a second cycle the total eradication rate was 91.4%, after a third cycle the rate increased to 94.2%. No patient discontinued the antiseptic treatment due to dermal intolerance of the product. Progressive eradication of MRSA carriage was observed with the antiseptic soap and mupirocin. The eradication rate was not biased by concomitant antibiotic treatment, screening during treatment or lack of evidence for colonization in contrast to other studies with other preparations.Keywords
This publication has 24 references indexed in Scilit:
- Inducibility and potential role of MecA-gene-positive oxacillin-susceptible Staphylococcus aureus from colonized healthcare workers as a source for nosocomial infectionsJournal of Hospital Infection, 2003
- Decolonization of methicillin-resistant Staphylococcus aureus using oral vancomycin and topical mupirocinClinical Microbiology & Infection, 2002
- Laboratory Characterization of Methicillin‐ResistantStaphylococcus aureusin Canadian Hospitals: Results of 5 Years of National Surveillance, 1995–1999The Journal of Infectious Diseases, 2002
- First Case of VRSA Identified in MichiganInfection Control & Hospital Epidemiology, 2002
- Occurrence of methicillin-resistant Staphylococcus aureus infections in German intensive care units.Infection, 2002
- Community-acquired methicillin-resistant Staphylococcus aureus infections in South Texas childrenThe Pediatric Infectious Disease Journal, 2001
- Methicillin-ResistantStaphylococcus aureus in EuropeEuropean Journal of Clinical Microbiology & Infectious Diseases, 1994
- Randomized double-blinded trial of rifampin with either novobiocin or trimethoprim-sulfamethoxazole against methicillin-resistant Staphylococcus aureus colonization: prevention of antimicrobial resistance and effect of host factors on outcomeAntimicrobial Agents and Chemotherapy, 1993
- Revised guidelines for the control of epidemic methicillin-resistant Staphylococcus aureus. Report of a combined working party of the Hospital Infection Society and British Society for Antimicrobial Chemotherapy.1990
- Attemps to eradicate methicillin-resistant Staphylococcus aureus colonization with the use of trimethoprim-sulfamethoxazole, rafampin, and bacitracinAmerican Journal of Infection Control, 1988